Scarica l'app Stockscreener
14.05
1.40%
0.11
Precedente Chiudi:
$13.94
Aprire:
$14.1
Volume 24 ore:
404.22K
Relative Volume:
0.25
Capitalizzazione di mercato:
$1.84B
Reddito:
$3.34B
Utile/perdita netta:
$97.10M
Rapporto P/E:
-23.61
EPS:
-0.595
Flusso di cassa netto:
$208.00M
1 W Prestazione:
-5.95%
1M Prestazione:
-13.28%
6M Prestazione:
-9.04%
1 anno Prestazione:
-38.17%
Intervallo 1D:
$13.79
$14.18
Intervallo di 1 settimana:
$13.52
$14.99
Portata 52W:
$11.41
$23.79
Surgery Partners Inc Stock (SGRY) Company Profile
Nome
Surgery Partners Inc
Settore
Industria
Telefono
615-234-5900
Indirizzo
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, EHC, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
14.06 | 1.78B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
429.65 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
279.40 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.51 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.22 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
175.66 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Ripresa | JP Morgan | Neutral |
| 2025-07-28 | Ripresa | BofA Securities | Buy |
| 2024-12-16 | Iniziato | BofA Securities | Buy |
| 2024-10-14 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Iniziato | Macquarie | Outperform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-11-14 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-05-12 | Iniziato | Mizuho | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-06-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-11-30 | Iniziato | Barclays | Overweight |
| 2021-11-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-11-01 | Iniziato | JP Morgan | Neutral |
| 2021-10-18 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-06-23 | Ripresa | Stifel | Hold |
| 2020-09-17 | Reiterato | The Benchmark Company | Buy |
| 2020-04-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Reiterato | The Benchmark Company | Buy |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-09-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Aggiornamento | Stifel | Sell → Hold |
| 2018-01-30 | Reiterato | The Benchmark Company | Buy |
| 2017-11-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Downgrade | Stifel | Hold → Sell |
| 2017-04-24 | Reiterato | Stifel | Hold |
| 2017-03-10 | Downgrade | Stifel | Buy → Hold |
| 2017-01-31 | Iniziato | The Benchmark Company | Buy |
| 2016-06-10 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-10-27 | Iniziato | Stifel | Buy |
| 2015-10-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-10-26 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Surgery Partners Inc Borsa (SGRY) Ultime notizie
Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com
Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Canada
Surgery Partners (SGRY) Insider Teresa Deluca Purchases 10,000 S - GuruFocus
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat - Yahoo Finance
Surgery Partners Director Teresa DeLuca Acquires 10,000 Shares at $14.35 Each - Kalkine Media
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - Sahm
Surgery Partners Beats Q2 Estimates, Divests Idaho Falls Hospitals in Strategic Pivot - finance.biggo.com
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - Moomoo
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada
TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo
Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat
Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm
Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK
Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus
Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang
SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria
SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com
Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa
Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com
SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance
Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail
Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - Seeking Alpha
Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media
Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan
Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet
Surgery Partners: Q2 Earnings Snapshot - AOL.com
Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet
SGRY Looks 42.7% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats - Investing.com Nigeria
Surgery Partners Q2 Earnings Call Highlights - MarketBeat
Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Surgery Partners shares edge lower despite Q2 revenue beat - Yahoo Finance
Surgery Partners Announces Q2 and H1 2026 Financial Results with Investor Call - Kalkine Media
Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com Canada
Transcript : Surgery Partners, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Surgery Partners, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Surgery Partners beats revenue but misses on earnings By Investing.com - Investing.com Canada
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Surgery Partners Inc Azioni (SGRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):